MedTrace Logo

Comparative Study Between Biodentine and Mineral Trioxide Aggregate in Direct Pulp Capping

NCT02803528 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2018-01-03

No results posted yet for this study

Summary

Comparative study between Biodentine and MTA in direct pulp capping of deeply carious teeth.

Conditions

  • Patients With Deep Carious Lesions

Interventions

DRUG

Biodentine

Biodentine is going to be used as the direct pulp capping material

DRUG

MTA

MTA is going to be used as the direct pulp capping material in the second group

Sponsors & Collaborators

  • Damascus University

    lead OTHER

Principal Investigators

  • Mohammad MN Aldakak, DDS MSc · PhD Student in Operative Dentistry

  • Souad Abboud, DDS MSc PhD · Associate Professor of Operative Dentistry, University of Damascus Dental School, Damascus, Syria

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2017-01-20
Completion
2017-10-20

Countries

  • Syria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02803528 on ClinicalTrials.gov